Cormorant Asset Management’s Verve Therapeutics VERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-350,000
| Closed | -$1.97M | – | 47 |
|
|
2024
Q4 | $1.97M | Hold |
350,000
| – | – | 0.11% | 46 |
|
|
2024
Q3 | $1.69M | Hold |
350,000
| – | – | 0.09% | 43 |
|
|
2024
Q2 | $1.71M | Hold |
350,000
| – | – | 0.1% | 46 |
|
|
2024
Q1 | $4.65M | Hold |
350,000
| – | – | 0.2% | 53 |
|
|
2023
Q4 | $4.88M | Hold |
350,000
| – | – | 0.23% | 40 |
|
|
2023
Q3 | $4.64M | Hold |
350,000
| – | – | 0.27% | 39 |
|
|
2023
Q2 | $6.56M | Hold |
350,000
| – | – | 0.37% | 44 |
|
|
2023
Q1 | $5.05M | Hold |
350,000
| – | – | 0.33% | 47 |
|
|
2022
Q4 | $6.77M | Sell |
350,000
-250,000
| -42% | -$4.84M | 0.45% | 47 |
|
|
2022
Q3 | $20.6M | Sell |
600,000
-100,710
| -14% | -$3.46M | 1.44% | 26 |
|
|
2022
Q2 | $10.7M | Hold |
700,710
| – | – | 0.81% | 38 |
|
|
2022
Q1 | $16M | Sell |
700,710
-408,514
| -37% | -$9.32M | 1.23% | 22 |
|
|
2021
Q4 | $40.9M | Buy |
1,109,224
+400,000
| +56% | +$14.7M | 2.43% | 11 |
|
|
2021
Q3 | $32.7M | Hold |
709,224
| – | – | 1.33% | 22 |
|
|
2021
Q2 | $40.6M | Buy |
+709,224
| New | +$40.6M | 1.38% | 22 |
|